Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3–10.

Article  PubMed  Google Scholar 

Zajdel P, Marciniec K, Ma A, Lenda T, Siwek A, Nowak G, et al. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors. Eur J Med Chem. 2013;60:42–50.

Article  CAS  PubMed  Google Scholar 

Mcintyre RS, Yoon J, Jerrell MJ, Liauw SS. Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence. Neuropsychiatr Dis Treat. 2011;7:319–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butreddy A, Sarabu S, Bandari S, Dumpa N, Zhang F, Repka MA. Polymer-assisted aripiprazole-adipic acid cocrystals produced by hot melt extrusion techniques. Cryst Growth Des. 2020;20(7):4335–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silki, Sinha VR. Enhancement of in vivo efficacy and oral bioavailability of aripiprazole with solid lipid nanoparticles. AAPS PharmSciTech. 2018;19(3):1264–1273.

Ghadi R, Dand N. BCS class IV drugs: highly notorious candidates for formulation development. J Control Release. 2017;248:71–95.

Article  CAS  PubMed  Google Scholar 

He Y, Liang S, Long M, Xu H. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mater Sci Eng C Mater Biol Appl. 2017;78:12–7.

Article  CAS  PubMed  Google Scholar 

Savjani KT, Gajjar AK, Savjani JK. Drug solubility : importance and enhancement techniques. ISRN Pharm. 2012;195727:1–10.

Google Scholar 

Danısman-Kalındemirtaş F, Kari̇per IA, Hepokur C, Erdem-Kuruca S. Selective cytotoxicity of paclitaxel bonded silver nanoparticle on different cancer cells. J Drug Deliv Sci Technol. 2021;61:102265.

Huang R, Shen Y, Guan Y, Jiang Y, Wu Y, Rahman K, et al. Mesoporous silica nanoparticles : facile surface functionalization and versatile biomedical applications in oncology. Acta Biomater. 2020;116:1–15.

Article  CAS  PubMed  Google Scholar 

Jafari S, Derakhshankhah H, Alaei L, Fattahi A, et al. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother. 2019;109:1100–11.

Article  CAS  PubMed  Google Scholar 

Meynen V, Cool P, Vansant EF. Verified syntheses of mesoporous materials. Microporous Mesoporous Mater. 2009;125(3):170–223.

Article  CAS  Google Scholar 

Zhou J, Zhu F, Li J, Wang Y. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function. Mater Sci Eng C Mater Biol Appl. 2018;90:314–24.

Article  CAS  PubMed  Google Scholar 

Soltys M, Kovacik P, Dammer O, Beranek J, Stepanek F. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles. Int J Pharm. 2019;555:19–27.

Article  CAS  PubMed  Google Scholar 

Laine A, Price D, Davis J, Roberts D, Hudson R, Back K, et al. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS. Int J Pharm. 2016;512(1):118–25.

Article  CAS  PubMed  Google Scholar 

Jia L, Shen J, Li Z, Zhang D, Zhang Q, Duan C, et al. Successfully tailoring the pore size of mesoporous silica nanoparticles : exploitation of delivery systems for poorly water-soluble drugs. Int J Pharm. 2012;439(1–2):81–91.

Article  CAS  PubMed  Google Scholar 

Wang Z, Chen B, Quan G, Li F, Wu Q, Dian L, et al. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica. Int J Nanomedicine. 2012;7:5807–18.

CAS  PubMed  PubMed Central  Google Scholar 

Hong S, Shen S, Tan DCT, Ng WK, Liu X, Chia LSO, et al. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods. Drug Deliv. 2016;23(1):316–27.

Article  CAS  PubMed  Google Scholar 

Kiekens F, Eelen S, Verheyden L, Daems T, Martens J, Mooter G. Use of ordered mesoporous silica to enhance the oral bioavailability of ezetimibe in dogs. J Pharm Sci. 2012;101(3):1136–44.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Zhi Z, Li X, Gao J, Song Y. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol. Int J Pharm. 2013;454(1):403–11.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Wang J, Bai X, Jiang T, Zhang Q, Wang S. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm. 2012;9(3):505–13.

Article  CAS  PubMed  Google Scholar 

Biswas N. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan. Eur J Pharm Sci. 2017;99:152–60.

Article  CAS  PubMed  Google Scholar 

Abd-Elrahman AA, El Nabarawi MA, Hassan DH, Taha AA. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Drug Deliv. 2016;23(9):3387–98.

Article  CAS  PubMed  Google Scholar 

Dai W, Guo Y, Zhang H, Wang X, Zhang Q. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A. Int J Pharm. 2015;478(2):718–25.

Article  CAS  PubMed  Google Scholar 

Bukara K, Schueller L, Rosier J, Martens MA, Daems T, Verheyden L, et al. Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: proof of concept in man. Eur J Pharm Biopharm. 2016;108:220–5.

Article  CAS  PubMed  Google Scholar 

Braun DE, Gelbrich T, Kahlenberg V, Tessadri R, Wieser J, Griesser UJ. Stability of solvates and packing systematics of nine crystal forms of the antipsychotic drug aripiprazole. Cryst Growth Des. 2009;9(2):1054–65.

Article  CAS  Google Scholar 

Al-dhubiab BE. Aripiprazole nanocrystal impregnated buccoadhesive films for schizophrenia. J Nanosci Nanotechnol. 2017;17(4):2345–52.

Article  CAS  PubMed  Google Scholar 

McFall H, Sarabu S, Shankar V, Bandari S, Murthy SN, Kolter K, et al. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: in vitro and in vivo studies. Int J Pharm. 2019;554:302–11.

Article  CAS  PubMed  Google Scholar 

Mihajlovic T, Kachrimanis K, Graovac A, Djuric Z, Ibric S. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique. AAPS PharmSciTech. 2012;13(2):623–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahoo SK, Suresh P, Acharya U. Formulation development and bioavailability assessment of aripiprazole by self-nanoemulsifying drug delivery systems. Asian J Pharm. 2018;12(03):1059–68.

Google Scholar 

Mahmoud AA, Salama AH, Shamma RN. Bioavailability enhancement of aripiprazole via silicosan particles : preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2018;8:3751–62.

Article  Google Scholar 

Quan G, Pan X, Wang Z, Wu Q, Li G, Dian L, et al. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. J Nanobiotechnology. 2015;13(1):1–12.

Google Scholar 

Xu Y, Wang C, Zhou G, Wu Y, Chen J. Improving the controlled release of water-insoluble emodin from amino-functionalized mesoporous silica. Appl Surf Sci. 2012;258(17):6366–72.

Article  CAS  Google Scholar 

Shen S, Ng WK, Chia L, Dong YC, Tan RB. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. J Pharm Sci. 2010;99(4):1997–2007.

Article  CAS  PubMed  Google Scholar 

Mihai I, Laura T, Adriana S, Gabriela L, Paul V, Renata B, et al. Physicochemical characterization and molecular modeling study of host-guest systems of aripiprazole and functionalized cyclodextrins. J Therm Anal Calorim. 2020;141:1027–39.

Article  Google Scholar 

Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release. 2010;145(3):257–63.

Article  CAS  PubMed  Google Scholar 

Geng H, Zhao Y, Liu J, Cui Y, Wang Y, Zhao Q, et al. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release. Int J Pharm. 2016;510(1):184–94.

Article  CAS  PubMed  Google Scholar 

Rahmat N, Sadon N, Yusof MA. Thermogravimetric analysis (TGA) profile at different calcination conditions for synthesis of PTES-SBA-15. Am J Appl Sci. 2017;14(10):938–44.

Article  CAS  Google Scholar 

Jadhav SA, Brunella V, Scalarone D, Berlier G. Poly (NIPAM-co-MPS)-grafted multimodal porous silica nanoparticles as reverse thermoresponsive drug delivery system. Asian J Pharm Sci. 2017;12(3):279–84.

Article  PubMed  PubMed Central